. Author manuscript; available in PMC: 2016 Dec 1.

Published in final edited form as: Pharm Res. 2015 Jun 26;32(12):3827–3836. doi: 10.1007/s11095-015-1743-x

Table II. Evaluation of anti-Pfs25 antibody titers in mice immunized with CHrPfs25.

(a) CHrPfs25 adsorbed to alum and vaccinated via IP and IM routes
		Antibody titers
Groups	Prime (Day 21)	1^st Boost (Day 31)	2^nd Boost (Day 52)
IP	0	320,000	640,000
IM	800	320,000	640,000
(b) CHrPfs25 admixed with NE and PGA-NPs administered via IM route
		Antibody titers
Groups	Prime (Day 21)	1^st Boost (Day 31)	2^nd Boost (Day 52)
8% NE	400	160,000	320,000
4% NE	800	320,000	640,000
4% NE+MPL-A	400	80,000	640,000
4% NE+Chitosan	0	20,000	640,000
PLGA-NP (20 mg/mL)	800	80,000	320,000
PLGA-NP (10 mg/mL)	800	20,000	160,000